0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Circulating Factor VIII Anticoagulant in Bullous Dermatitis

JEREMY V. COOKE, M.D.; JOHN B. ANDERSON, B.A.; WILLARD S. GAMBLE, M.D.
Arch Intern Med. 1962;110(4):511-515. doi:10.1001/archinte.1962.03620220103016.
Text Size: A A A
Published online

A circulating anticoagulant as the cause of a prolonged clotting time was described in 1906 by Weil.1 An excellent review of this subject has recently appeared in which anticoagulants against Factors I, V, VII, VIII, IX, XI, and XII have been defined.2 They have been reported in a variety of diseases including systemic lupus erythematosus, dysproteinemias, liver disease, and penicillin and transfusion reactions as well as generalized skin diseases. Two cases of dermatitis herpetiformis3,4 and 2 cases of pemphigus vulgaris5,6 were found to have an anticoagulant against an unspecified factor in the first stage of clotting. A fifth case of a vesiculobullous eruption7 was found to have an anticoagulant against tissue thromboplastin. We wish to report a case of generalized bullous dermatitis associated with an anticoagulant against Factor VIII (antihemophilic globulin). We are unaware of any previous case report of a specific anticoagulant against Factor

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();